Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

If approved, the pump would be able to integrate with a continuous glucose monitoring sensor on Abbott's platform. Medtronic also submitted an application seeking clearance for its SmartGuard ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous glucose monitor, following a similar approval for the pairing in Europe ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM ... Boehringer, Medtronic, Abbott, DreaMed Diabetes, Indigo Diabetes, Dexcom, and Roche.